Not investment advice. Educational platform. See Disclaimer.
NYSE: ELAN
Elanco Animal Health Incorporated
Healthcare | Drug Manufacturers - Specialty & Generic
$22.75+0.00 (+0.00%)as of 2026-07-14 21:21 UTC
Market Cap$11.4B
Volume3.08M
EPS (TTM)$-0.47
Elanco Animal Health Incorporated (NYSE: ELAN) is a $11.4B drug manufacturers - specialty & generic company trading at $22.75. Figures from SEC EDGAR and market feeds; updated 2026-07-14 21:21 UTC.
52-Week Range
Low $9.14High $27.72
What Elanco Animal Health Incorporated does
This company operates in animal health, producing products for both pet and farm animals including antibiotics, antiparasitic treatments like the Seresto collar, and ionophore-based products. The business faces competition from generic alternatives as patents expire, with a competitor already selling a generic version of Seresto in the U.S. before certain patent protections end.
Summarized from Elanco Animal Health Incorporated’s SEC filings · Read the filing ↗
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
This company operates in animal health, producing products for both pet and farm animals including antibiotics, antiparasitic treatments like the Seresto collar, and ionophore-based products.
What is ELAN's valuation?
ELAN trades at $22.75, as of 2026-07-14.
When did ELAN last file with the SEC?
Elanco Animal Health Incorporated's most recent SEC filing on record is a 8-K filed 2026-05-27. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-14 21:21 UTC. This page is also available as JSON at /api/data?ticker=ELAN and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ELAN and 3,500+ tickers.
